SHPH
Shuttle Pharmaceuticals Holdings, Inc.Price
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- May 1 ▼ Shuttle Pharmaceuticals entered into a merger agreement with United…
- May 7 ▼ Shuttle Pharmaceuticals completed its merger with United Dogecoin In…
- Jun 29 to Jul 10 ▲ 6 days of insider buys: $181.8K by 1 insider, avg $3.40
- Jul 6 to Jul 14 ▼ 5 days of insider sells: $504.8K by 1 insider, avg $4.16
- Aug 31 ▲ Short interest falls 25.7% to 39.3K
- Sep 15 ▲ Short interest falls 44.1% to 22.0K
- Oct 15 ▼ Short interest jumps 76.0% to 31.3K
- Oct 22 ▼ Shuttle Pharmaceuticals dismissed its auditor, Forvis Mazars, effect…
- Oct 30 ▲ Short interest falls 52.2% to 15.0K
Signal stack
Where each data set points today.
- InsidersBEARISH
1 insider bought $181.8K at an average $3.40. 1 insider sold $504.8K. Price is 25% above their cost.
- InstitutionsMIXED
Q4 2025: 2 added (0 new), 0 trimmed or exited.
- Short sellersCOVERING
Short interest −52.2% to 15.0K shares. 1.0 days to cover, ≈0.3% of shares.
- TrendDOWNTREND
6% below its 50-day average.
Who's buying
13F· Q4 2025| Fund | Move | Value |
|---|---|---|
| UBS Group AG | DOUBLED | $21.5K |
| BANK OF AMERICA CORP /DE/ | ADD | $22.00 |
| UBS Group AG | NEAR_EXIT | $28.00 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | $28.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
HRT FINANCIAL LP 10%+ Owner Jul 14, 2026 | SELL | $367.9K |
HRT FINANCIAL LP 10%+ Owner Jul 13, 2026 | SELL | $4.8K |
HRT FINANCIAL LP 10%+ Owner Jul 10, 2026 | BUY | $2.3K |
HRT FINANCIAL LP 10%+ Owner Jul 9, 2026 | BUY | $27.9K |
HRT FINANCIAL LP 10%+ Owner Jul 8, 2026 | SELL | $65.2K |
HRT FINANCIAL LP 10%+ Owner Jul 7, 2026 | SELL | $35.2K |
HRT FINANCIAL LP 10%+ Owner Jul 6, 2026 | SELL | $31.7K |
HRT FINANCIAL LP 10%+ Owner Jul 2, 2026 | BUY | $27.8K |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | None | None | No data | $0.00 |
| Next Q | None | None | No data | $0.00 |
| Current FY | None | None | No data | $0.00 |
| Next FY | None | None | No data | $0.00 |
Short side
FINRA· Oct 30, 2026SecBot reports
9 filings · 0 bullish · 3 bearish · 6 neutral- NEUTRAL 8-KNov 6, 2026
Shuttle Pharmaceuticals dismissed Forvis Mazars, LLP as its auditor and engaged Bush & Associates…
Monitor the next 10-K for Bush & Associates' audit opinion and any material weaknesses or going concern disclosures that may surface under the new auditor.
- BEARISH 8-KOct 22, 2026
Shuttle Pharmaceuticals dismissed its auditor, Forvis Mazars, effective after the Q3 2026 10-Q…
Watch for the engagement of a new auditor and the timely filing of the Q3 2026 10-Q. Failure to file on time or a further delay in auditor engagement could trigger Nasdaq listing issues and further…
- NEUTRAL 8-KSep 1, 2026
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) amended its merger agreement with United Dogecoin…
This filing reduces the mining rig count needed to trigger milestone-based warrant issuances but does not change the maximum warrant pool. Monitor progress toward the new threshold and any updates…
- NEUTRAL 3Jul 13, 2026
HRT Financial LP filed a Form 3 initial statement of beneficial ownership, disclosing direct…
This filing is a standard initial ownership report with no trading or corporate action. Monitor for subsequent Form 4 filings by HRT Financial LP to detect any future buying or selling activity.
All SHPH filing & press-release reports (9)
- 8-K reportNov 6, 2026
- 8-K reportOct 22, 2026
- 8-K reportSep 1, 2026
- 3 reportJul 13, 2026
- 3 reportJul 1, 2026
- 8-K reportJun 11, 2026
- 8-K reportMay 7, 2026
- 8-K reportMay 1, 2026
- 8-K reportMar 10, 2026